General Information of Drug (ID: DMESEBN)

Drug Name
Pritumumab
Indication
Disease Entry ICD 11 Status REF
Glioma 2A00.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0H6ZA

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)